Romania vs Singapore: Hepatitis B surface antigen (HBsAg) prevalence
Romania
0.1%
in 2024
Singapore
0.1%
in 2024
Romania rank
101st
Singapore rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Romania
- Singapore
How they compare
Romania currently reports 0.1% against 0.1% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Singapore ahead.
Romania ranks 101st and Singapore ranks 101st of 194 countries.
Head to head by decade
| Decade | Romania | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Romania or Singapore?
- Romania, at 0.1% against 0.1% in Singapore as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Romania and Singapore?
- 0.0%, with Romania ahead.
- How many years of comparable data are there for Romania and Singapore?
- 10 years are reported by both, from 2015 to 2024.
- How do Romania and Singapore rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Romania ranks 101st and Singapore ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.